[Long-term results of therapy of primary hypothyroidism in relation to immune status].
Disorders in the immune status of patients with hypothyroidism (idiopathic and postoperative) produce a negative effect on a course of disease. Periods of decompensation (exacerbation) develop in such patients more frequently than in patients suffering from hypothyroidism with the normally or moderately changed immune status.
Epishin
A V
AV
Grytsiv
V E
VE
Sivak
L I
LI
Venger
E P
EP
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000276:immunology* / Q000628:therapy*; D007109:Immunity; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D013946:Thymopoietins / Q000627:therapeutic use; D013997:Time Factors
D000276:Adjuvants, Immunologic; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009696:Nucleic Acids; D013946:Thymopoietins; C032841:thymopoietin III; C013683:sodium nucleinate
Otdalennye rezultaty terapii pervichnogo gipotireoza v zavisimosti ot immunnogo statusa.